Company intelligence / Profile preview

Bactools Biotech

Ownership: Private
Development stage: Commercial

Overview

Bactools Biotech develops and commercializes high-quality biotechnological solutions—primarily spore-based microbial products—to enhance agricultural productivity while reducing environmental impact. Their offerings include solid or liquid formulations with single strains or consortia tailored to specific agricultural needs. The company emphasizes innovation in applied microbiology for sustainable farming.

Therapeutic areas: Other
Modalities: Microbiological products (spores of bacteria/fungi)biomoleculesbionutrients
Industry: Agriculture & AgTech

Beyond the preview

Go deeper on Bactools Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bactools Biotech.

Explore the full profile